Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes

Transplantation

Volumn 98, Issue 5, 2014, Pages 557-562

  Sharpton, Suzanne R ^a   Feng, Sandy ^a   Hameed, Bilal ^a   Yao, Francis ^a   Lai, Jennifer C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

graft loss; MELD; recipient age

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHOLESTASIS; DISEASE ASSOCIATION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HAZARD RATIO; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; NONALCOHOLIC FATTY LIVER; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; YOUNG ADULT; ADOLESCENT; END STAGE LIVER DISEASE; EVALUATION STUDY; KAPLAN MEIER METHOD; PROPORTIONAL HAZARDS MODEL; REGISTER; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907597488     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000090     Document Type: Article

References (13)

1. Based on UNOS/OPTN data as of July 20, 2012.
2. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945Y1965. MMWR Recomm Rep. 2012; 61: 1.
3. Charlton MR, Burns JM, Pedersen RA, et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology 2011; 141: 1249.
4. Levy MF, Somasundar PS, Jennings LW, et al. The elderly liver transplant recipient: A call for caution. Ann Surg 2001; 233: 107.
5. Burra P, Martin ED, Gitto S, et al. Influence of age and gender before and after liver transplantation. Liver Transpl 2013; 19: 122.
6. Dutkowski P, Oberkofler CE, Slankamenac K, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg 2011; 254: 745.
7. Herrero JI, Lucena JF, Quiroga J, et al. Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 2003; 3: 1407.
8. Keswani RN, Ahmed A, Keeffe EB. Older age and liver transplantation: A review. Liver Transpl 2004; 10: 957.
9. Cross TJ, Antoniades CG, Muiesan P, et al. Liver transplantation in patients over 60 and 65 years: An evaluation of long-term outcomes and survival. Liver Transpl 2007; 13: 1382.
10. Aloia TA, Knight R, Gaber AO, et al. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver diseaseindependent prognostic factors. Liver Transpl 2010; 16: 950.
11. Taner CB, Ung RL, Rosser BG, et al. Age is not a contraindication for orthotopic liver transplantation: A single institution experience with recipients older than 75 years. Hepatol Int 2012; 6: 403.
12. Yoshizumi T, Shirabe K, Soejima Y, et al. Living donor liver transplantation in patients older than 60 years. Transplantation 2010; 90: 433.
13. OPTN-UNOS Policy 3.6V Allocation of Livers. 2012 Jul. pp. 1-25.